期刊
MOLECULAR PHARMACEUTICS
卷 18, 期 1, 页码 359-376出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.molpharmaceut.0c00986
关键词
respiratory syncytial virus; nanoparticle vaccine; fusion glycoprotein; small-angle neutron scattering; polysorbate micelle
资金
- EPSRC [EP/K039121/1] Funding Source: UKRI
The RSV fusion protein/PS80 nanoparticle vaccine is an advanced vaccine for maternal immunization and protection of newborns against RSV infection. The structure and hydrodynamic properties of the vaccine were studied, revealing details of antigen presentation and nanoparticle assembly involving PS80 and RSV F trimers. This study demonstrates a general strategy for structurally characterizing nanoparticle vaccines using small-angle scattering methods.
The respiratory syncytial virus (RSV) fusion (F) protein/polysorbate 80 (PS80) nanoparticle vaccine is the most clinically advanced vaccine for maternal immunization and protection of newborns against RSV infection. It is composed of a near-full-length RSV F glycoprotein, with an intact membrane domain, formulated into a stable nanoparticle with PS80 detergent. To understand the structural basis for the efficacy of the vaccine, a comprehensive study of its structure and hydrodynamic properties in solution was performed. Small-angle neutron scattering experiments indicate that the nanoparticle contains an average of 350 PS80 molecules, which form a cylindrical micellar core structure and five RSV F trimers that are arranged around the long axis of the PS80 core. All-atom models of full-length RSV F trimers were built from crystal structures of the soluble ectodomain and arranged around the long axis of the PS80 core, allowing for the generation of an ensemble of conformations that agree with small-angle neutron and X-ray scattering data as well as transmission electron microscopy (TEM) images. Furthermore, the hydrodynamic size of the RSV F nanoparticle was found to be modulated by the molar ratio of PS80 to protein, suggesting a mechanism for nanoparticle assembly involving addition of RSV F trimers to and growth along the long axis of the PS80 core. This study provides structural details of antigen presentation and conformation in the RSV F nanoparticle vaccine, helping to explain the induction of broad immunity and observed clinical efficacy. Small-angle scattering methods provide a general strategy to visualize surface glycoproteins from other pathogens and to structurally characterize nanoparticle vaccines.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据